Starpharma Holdings Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Starpharma Holdings Limited generated cash of -$6,977,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,747,000 last year. Net change in cash is therefore -$11,820,000.
Cash Flow
| 2015 | -13.61M | -653K | 20.47M |
|---|---|---|---|
| 2016 | -17.81M | 29K | 32.56M |
| 2017 | -16.95M | 32.65M | -21K |
| 2018 | -10.20M | -359K | -26K |
| 2019 | -10.34M | -306K | -26K |
| 2020 | -10.77M | -125K | -584K |
| 2021 | -14.80M | -246K | 46.30M |
| 2022 | -13.16M | -836K | 3.22M |
| 2023 | -13.53M | -610K | -695K |
| 2024 | -6.97M | -89K | -4.74M |
SPHRY Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 35.18M | 49.91M | 60.5M | 30.05M | 41.25M | 51.31M | 61.18M | 45.97M | 30.84M | 24.02M |
Operating activities | ||||||||||
Net income | -8.16M | -15.63M | -16.15M | -19.73M | -14.67M | -14.25M | -10.28M | -15.21M | -21.29M | -18.95M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 1.19M | 1.07M | 935K | 911K | 298K | 311K | 318K | 288K | 1.22M |
Stock-based compensation expense | 0 | 2.06M | 2.24M | 3.73M | 3.60M | 3.37M | 0 | 2.24M | 1.67M | 1.42M |
| Deferred income tax benefit | 0 | 2.06M | 2.24M | 3.73M | 3.60M | 3.37M | 0 | 2.24M | 1.67M | 1.42M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -1.25M | 629K | -2.36M | 31K | -23K | -1.75M | -344K | -93K | 370K |
Inventories | 0 | 51K | -1.10M | -1.22M | -95K | -399K | 0 | 0 | 0 | 0 |
Accounts payable | -3.65M | -84K | 289K | 2.93M | -445K | 1.14M | -847K | -4.28M | 2.90M | 0 |
Cash generated by operating activities | -6.97M | -13.53M | -13.16M | -14.80M | -10.77M | -10.34M | -10.20M | -16.95M | -17.81M | -13.61M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -126K | 0 |
Investments In Property Plant And Equipment | -89K | -621K | -837K | -246K | -125K | -314K | -359K | -625K | -97K | -653K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.28M | 1K | 0 |
Cash generated by investing activities | -89K | -610K | -836K | -246K | -125K | -306K | -359K | 32.65M | 29K | -653K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 48.86M | 0 | 0 | 0 | 0 | 32.59M | 21.41M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.35M | -32K |
Repurchases of common stock | 0 | 0 | 0 | -1.93M | 0 | 0 | 0 | 0 | -1.31M | -916K |
Repayments of term debt | -4.00M | 0 | 4M | -628K | -584K | 0 | -26K | 0 | -32K | 0 |
Cash used in financing activities | -4.74M | -695K | 3.22M | 46.30M | -584K | -26K | -26K | -21K | 32.56M | 20.47M |
Net Change In Cash | -11.82M | -14.73M | -10.58M | 30.44M | -11.19M | -10.06M | -9.86M | 15.21M | 15.12M | 6.82M |
Cash at end of period | 23.36M | 35.18M | 49.91M | 60.5M | 30.05M | 41.25M | 51.31M | 61.18M | 45.97M | 30.84M |